High-throughput detection of fusion genes in cancer using the Sequenom MassARRAY platform (Q39496666)

12 September 2017

High-throughput detection of fusion genes in cancer using the Sequenom MassARRAY platform (English)

1 reference

12 September 2017

12

Jorge S Reis-Filho

1 reference

12 September 2017

3

Rachael Natrajan

1 reference

12 September 2017

2

Paul M Wilkerson

1 reference

12 September 2017

1

Maryou B K Lambros

1 reference

12 September 2017

6

Radost Vatcheva

1 reference

12 September 2017

5

Vidya Pawar

1 reference

12 September 2017

4

Neill Patani

1 reference

12 September 2017

7

Marthe Mansour

1 reference

12 September 2017

Mirja Laschet

8

1 reference

12 September 2017

Beatrice Oelze

series ordinal

9

1 reference

12 September 2017

Nicholas Orr

series ordinal

10

1 reference

12 September 2017

Susanne Muller

series ordinal

11

1 reference

12 September 2017

1 August 2011

1 reference

12 September 2017

Laboratory Investigation

1 reference

12 September 2017

91

1 reference

12 September 2017

1491-1501

1 reference

12 September 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.2011.110

12 September 2017

0 references

cites work

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

The impact of translocations and gene fusions on cancer causation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

Complex landscapes of somatic rearrangement in human breast cancer genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

Integrative analysis of the melanoma transcriptome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

Transcriptome sequencing to detect gene fusions in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

Chimeric transcript discovery by paired-end transcriptome sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

Testing mutual exclusivity of ETS rearranged prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

ETV6-NTRK3--Trk-ing the primary event in human secretory breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6'split apart' probes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

Adenoid cystic carcinomas of the breast and salivary glands (or 'The strange case of Dr Jekyll and Mr Hyde' of exocrine gland carcinomas).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

Multiplex genotyping of CYP3A4, CYP3A5, CYP2C9 and CYP2C19 SNPs using MALDI-TOF mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

Epidermal growth factor gene (EGF) polymorphism and risk of melanocytic neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

Large-scale determination of SNP allele frequencies in DNA pools using MALDI-TOF mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

Profiling critical cancer gene mutations in clinical tumor samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

REporting recommendations for tumour MARKer prognostic studies (REMARK)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

Genetic association of rs11610206 SNP on chromosome 12q13 with late-onset Alzheimer's disease in a Han Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

Genomic profile of a secretory breast cancer with an ETV6-NTRK3 duplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

inferred from DOI database lookup

7 January 2021

based on heuristic

ETV6 gene rearrangements in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

inferred from DOI database lookup

7 January 2021

based on heuristic

Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.110

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LABINVEST.2011.110

1 reference

Dimensions Publication ID

12 September 2017

1011100030

0 references

Fatcat ID

release_cjithb46bbabtejg2km6ctoazq

0 references

1 reference